Current Issue
Alert me when new journal issues are available via or via
Masthead page IFC Full-Text PDF (33 KB)
Editorial Board page i Full-Text PDF (58 KB)
Contents pages ii-iii Full-Text PDF (48 KB)
News and Topics
Interest in conflicts anyone?, 14 December 2009 William Donald Steers pages 119-120 Full Text | Full-Text PDF (90 KB)
Review Articles
A survey of therapy for advanced renal cell carcinoma, 06 July 2009 Michele Basso, Alessandra Cassano, Carlo Barone pages 121-133 Abstract | Full Text | Full-Text PDF (342 KB)
Mammalian target of rapamycin: A new target in prostate cancer, 15 June 2009 Jaskarn S. Rai, Michael J. Henley, Hari L. Ratan pages 134-138 Abstract | Full Text | Full-Text PDF (312 KB)
Original Articles
Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention, 06 July 2009 Michael Staehler, Nico Haseke, Ekaterina Zilinberg, Thomas Stadler, Alexander Karl, Michael Siebels, Hans-Roland Dürr, Sabine Siegert, Karl W. Jauch, Christiane J. Bruns, Christian G. Stief pages 139-144 Abstract | Full Text | Full-Text PDF (2423 KB)
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy, 13 October 2008 Hideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi, Atsushi Takenaka, Masato Fujisawa pages 145-151 Abstract | Full Text | Full-Text PDF (334 KB)
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone, 13 October 2008 Orazio Caffo, Teodoro Sava, Evi Comploj, Maria Anna Giampaolo, Romana Segati, Francesco Valduga, Gianluigi Cetto, Enzo Galligioni pages 152-156 Abstract | Full Text | Full-Text PDF (145 KB)
Molecular biomarkers for advanced renal cell carcinoma: Implications for prognosis and therapy, 03 November 2008 Hyo Song Kim, Won Seog Kim, Se Hoon Park, Chul Won Jung, Han Yong Choi, Hyun Moo Lee, Seong Soo Jeon, Hongil Ha, In Gyu Hwang, Seungkoo Lee, Ho Yeong Lim pages 157-163 Abstract | Full Text | Full-Text PDF (963 KB)
Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector, 28 April 2008 Degui Wang, Zhiping Wang, Junqiang Tian, Xiangdong He, Wasim H. Chowdhury, Xiangbo Zhang, Shigang Li, Ronald Rodriguez pages 164-169 Abstract | Full Text | Full-Text PDF (642 KB)
Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth, 26 September 2008 Szu-Yuan Ping, Tzyh-Chyuan Hour, Shinne-Ren Lin, Dah-Shyong Yu pages 170-179 Abstract | Full Text | Full-Text PDF (1589 KB)
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines, 15 December 2008 Hervé Wallerand, Ying Cai, Zev A. Wainberg, Isla Garraway, Isabelle Lascombe, Gaëlle Nicolle, Jean-Paul Thiery, Hugues Bittard, François Radvanyi, Robert R. Reiter pages 180-188 Abstract | Full Text | Full-Text PDF (1201 KB)
Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor, 17 April 2009 Domenico D'Arca, James LeNoir, Bernadette Wildemore, Fedra Gottardo, Emma Bragantini, Dolores Shupp-Byrne, Nicola Zanesi, Matteo Fassan, Carlo M. Croce, Leonard G. Gomella, Raffaele Baffa pages 189-194 Abstract | Full Text | Full-Text PDF (565 KB)
Seminar Section Introduction
Positive surgical margins at radical prostatectomy: Do they really matter? Samir S. Taneja pages 195-196 Full Text | Full-Text PDF (85 KB)
Seminar Articles
Clinical significance of the positive surgical margin based upon location, grade, and stage Neil E. Fleshner, Andrew Evans, Karen Chadwick, Nathan Lawrentschuk, Alexandre Zlotta pages 197-204 Abstract | Full Text | Full-Text PDF (214 KB)
Margin control in open radical prostatectomy: What are the real outcomes? Michael S. Cookson, Sam S. Chang pages 205-209 Abstract | Full Text | Full-Text PDF (154 KB)
Margin control in robotic and laparoscopic prostatectomy: What are the REAL outcomes? Alon Z. Weizer, Seth Strope, David P. Wood pages 210-214 Abstract | Full Text | Full-Text PDF (137 KB)
Neurovascular bundle resection: Does it improve the margins? Herbert Lepor, Basir Tareen pages 215-218 Abstract | Full Text | Full-Text PDF (140 KB)
Radical prostatectomy: Does surgical technique influence margin control? Matthew T. Gettman, Michael L. Blute pages 219-225 Abstract | Full Text | Full-Text PDF (186 KB)
Letter To Editor
CA125 for following up carcinoma of the bladder, 07 January 2010 Viroj Wiwanitkit page 226 Full Text | Full-Text PDF (70 KB)
Survey Section Editorial Board page 227 Full-Text PDF (37 KB)
Urologic Oncology Survey
Commentary on The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth: Kutikov A, Uzzo RG, Department of Urological Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA Paul Russo page 228 Full Text | Full-Text PDF (83 KB)
Commentary on Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma: Verhoest G, Avakian R, Bensalah K, Thuret R, Ficarra V, Artibani W, Tostain J, Guille F, Cindolo L, De La Taille A, Abbou CC, Salomon L, Rioux-Leclercq N, Patard JJ, Rennes University Hospital, Rennes, France Paul Russo pages 228-229 Full Text | Full-Text PDF (95 KB)
Commentary on Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage 4N0 renal cell carcinoma) Capitanio U, Perrotte P, Zini L, Jeldres C, Shariat SF, Isbarn H, Arjane P, Peloquin F, Pharand D, Montorsi F, Karakiewicz PI, Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada Paul Russo pages 229-230 Full Text | Full-Text PDF (78 KB)
Commentary on Surgical resection of renal cell carcinoma after targeted therapy: Thomas AA, Rini BI, Stephenson AJ, Garcia JA, Fergany A, Krishnamurthi V, Novick AC, Gill IS, Klein EA, Zhou M, Campbell SC, Glickman Urological and Kidney Institute, Cleveland, OH Paul Russo pages 230-231 Full Text | Full-Text PDF (79 KB)
Commentary on Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: An expanded-access trial: Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Nieto A, Yuan J, Bukowski R, Royal Marsden Hospital NHS Trust, London, UK Paul Russo page 231 Full Text | Full-Text PDF (68 KB)
Commentary on Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance: Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG, Section of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Medical Center, Philadelphia, PA Paul Russo page 232 Full Text | Full-Text PDF (64 KB)
Information for Authors page IBC Full-Text PDF (36 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
